PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Arthritis 128,324 Disease Target Sphingosine 1-Phosphate Receptor 1 150 2 0.00 -0.99 0.01 0.55
Varicose Veins 5,072 Disease Target Elastase 13,875 7 0.00 -1.00 0.00 0.57
Arthritis 128,324 Disease Target Cardiotrophin-1 351 5 0.00 -0.99 0.01 0.55
Candidemia 1,512 Disease Target AFP 9,751 1 0.00 -1.00 0.00 0.55
Arthritis 128,324 Disease Target BMP-2 3,889 22 0.00 -1.00 0.01 0.54
Arthritis 128,324 Disease Target Complement Component C1q 167 4 0.00 -0.99 0.02 0.56
Arthritis 128,324 Disease Target Endoglin 1,333 8 0.00 -1.00 0.01 0.54
Arthritis 128,324 Disease Target Inosine-5'-Monophosphate Dehydrogenase 261 2 0.00 -1.00 0.01 0.54
Arthritis 128,324 Disease Target bFGF 9,327 79 0.00 -1.00 0.01 0.56
Arthritis 128,324 Disease Target CD-RAP 44 5 0.00 -0.94 0.11 0.59
Arthritis 128,324 Disease Target AXL 633 4 0.00 -1.00 0.01 0.54
Arthritis 128,324 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 7 0.00 -1.00 0.01 0.54
Arthritis 128,324 Disease Target ERBB3 1,154 2 0.00 -1.00 0.00 0.51
Arthritis 128,324 Disease Target BDNF 11,163 9 0.00 -1.00 0.00 0.49
Arthritis 128,324 Disease Target Elastase 13,875 222 0.01 -0.99 0.02 0.58
Arthritis 128,324 Disease Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.00 0.48
Arthritis 128,324 Disease Target BRAF 4,766 14 0.00 -1.00 0.00 0.52
Arthritis 128,324 Disease Target CD34 24,598 113 0.00 -1.00 0.00 0.54
Candidemia 1,512 Disease Target APOE 12,771 1 0.00 -1.00 0.00 0.54
Candidemia 1,512 Disease Target Dihydrofolate Reductase 5,563 1 0.00 -1.00 0.00 0.56
Arthritis 128,324 Disease Target CA 50 1,293 2 0.00 -1.00 0.00 0.50
Arthritis 128,324 Disease Target Macrophage Metalloelastase 100 3 0.00 -0.98 0.03 0.56
Varicose Veins 5,072 Disease Target CD34 24,598 2 0.00 -1.00 0.00 0.51
Varicose Veins 5,072 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 1 0.00 -1.00 0.00 0.58
Diabetic Nephropathy 12,496 Disease Target Epiregulin 291 1 0.00 -1.00 0.00 0.57
Diabetic Nephropathy 12,496 Disease Target APOA1 958 4 0.00 -1.00 0.00 0.59
Varicose Veins 5,072 Disease Target Carbonic Anhydrase 9 150 2 0.00 -0.99 0.01 0.63
Varicose Veins 5,072 Disease Target Cox-2 21,583 1 0.00 -1.00 0.00 0.50
Diabetic Nephropathy 12,496 Disease Target CXCL10/IP-10 114 1 0.00 -1.00 0.01 0.59
Varicose Veins 5,072 Disease Target Collagen 138,882 80 0.00 -0.99 0.02 0.57
Diabetic Nephropathy 12,496 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 4 0.00 -0.99 0.01 0.61
Diabetic Nephropathy 12,496 Disease Target Collagen 138,882 718 0.02 -0.97 0.06 0.63
Varicose Veins 5,072 Disease Target Endothelin A Receptor 722 1 0.00 -1.00 0.00 0.58
Diabetic Nephropathy 12,496 Disease Target CXCL9 1,016 2 0.00 -1.00 0.00 0.57
Diabetic Nephropathy 12,496 Disease Target Cox-2 21,583 34 0.00 -1.00 0.00 0.58
Varicose Veins 5,072 Disease Target APOE 12,771 1 0.00 -1.00 0.00 0.51
Varicose Veins 5,072 Disease Target Antithrombin 13,773 16 0.00 -1.00 0.00 0.59
Diabetic Nephropathy 12,496 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.58
Varicose Veins 5,072 Disease Target Urokinase-Type Plasminogen Activator 3,939 2 0.00 -1.00 0.00 0.56
Diabetic Nephropathy 12,496 Disease Target Exendin-4 855 6 0.00 -1.00 0.01 0.60
Diabetic Nephropathy 12,496 Disease Target Angiotensin-Converting Enzyme 2 665 27 0.01 -0.98 0.04 0.66
Varicose Veins 5,072 Disease Target Tissue-Type Plasminogen Activator 5,020 2 0.00 -1.00 0.00 0.56
Diabetic Nephropathy 12,496 Disease Target Sphingomyelinase 3,060 1 0.00 -1.00 0.00 0.52
Diabetic Nephropathy 12,496 Disease Target CD146 729 4 0.00 -1.00 0.01 0.60
Varicose Veins 5,072 Disease Target C7 7,027 1 0.00 -1.00 0.00 0.53
Diabetic Nephropathy 12,496 Disease Target Endothelin A Receptor 722 6 0.00 -1.00 0.01 0.61
Diabetic Nephropathy 12,496 Disease Target ERK2 3,287 3 0.00 -1.00 0.00 0.55
Diabetic Nephropathy 12,496 Disease Target Tissue-Type Plasminogen Activator 5,020 3 0.00 -1.00 0.00 0.54
Diabetic Nephropathy 12,496 Disease Target Adenosine Deaminase 6,613 2 0.00 -1.00 0.00 0.52
Varicose Veins 5,072 Disease Target bFGF 9,327 2 0.00 -1.00 0.00 0.54
Diabetic Nephropathy 12,496 Disease Target CCL2 3,560 32 0.00 -0.99 0.01 0.63
Diabetic Nephropathy 12,496 Disease Target Urokinase-Type Plasminogen Activator 3,939 5 0.00 -1.00 0.00 0.56
Diabetic Nephropathy 12,496 Disease Target Antithrombin 13,773 13 0.00 -1.00 0.00 0.56
Diabetic Nephropathy 12,496 Disease Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.61
Diabetic Nephropathy 12,496 Disease Target APOE 12,771 41 0.00 -1.00 0.00 0.61
Diabetic Nephropathy 12,496 Disease Target Alpha-Amylase 7,171 2 0.00 -1.00 0.00 0.52
Varicose Veins 5,072 Disease Target D-Dimer 6,185 15 0.00 -1.00 0.00 0.62
Varicose Veins 5,072 Disease Target Renin 43,456 2 0.00 -1.00 0.00 0.50
Diabetic Nephropathy 12,496 Disease Target Calcium Dependent Atpase 105 1 0.00 -1.00 0.01 0.59
Varicose Veins 5,072 Disease Target EGF 27,487 1 0.00 -1.00 0.00 0.49
Diabetic Nephropathy 12,496 Disease Target BMP-7 1,112 24 0.01 -0.99 0.02 0.65
Varicose Veins 5,072 Disease Target Platelet Activating Factor 9,915 3 0.00 -1.00 0.00 0.55
Diabetic Nephropathy 12,496 Disease Target CER 2,421 2 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target BRK 236 4 0.00 -0.99 0.02 0.59
Cervical Cancer 28,286 Disease Target EPHB1 137 1 0.00 -1.00 0.01 0.57
Dpdpe 1,204 Drug Target Multidrug Resistance-Associated Protein 2 462 2 0.00 -1.00 0.00 0.66
Anemia 81,663 Disease Target Inosine-5'-Monophosphate Dehydrogenase 261 2 0.00 -1.00 0.01 0.55
Anemia 81,663 Disease Target CALR 117 2 0.00 -0.99 0.02 0.56
Anemia 81,663 Disease Target bFGF 9,327 16 0.00 -1.00 0.00 0.52
Overactive Bladder 3,492 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 1 0.00 -1.00 0.00 0.59
Overactive Bladder 3,492 Disease Target bFGF 9,327 2 0.00 -1.00 0.00 0.55
Anemia 81,663 Disease Target AXL 633 1 0.00 -1.00 0.00 0.51
Overactive Bladder 3,492 Disease Target Multidrug Resistance-Associated Protein 2 462 1 0.00 -1.00 0.00 0.60
Anemia 81,663 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 6 0.00 -1.00 0.01 0.55
Overactive Bladder 3,492 Disease Target EGF 27,487 3 0.00 -1.00 0.00 0.53
Overactive Bladder 3,492 Disease Target Vanilloid Receptor 1 404 1 0.00 -1.00 0.00 0.60
Anemia 81,663 Disease Target BDNF 11,163 4 0.00 -1.00 0.00 0.48
Overactive Bladder 3,492 Disease Target Cox-2 21,583 6 0.00 -1.00 0.00 0.56
Anemia 81,663 Disease Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.00 0.49
Overactive Bladder 3,492 Disease Target Collagen 138,882 6 0.00 -1.00 0.00 0.51
Anemia 81,663 Disease Target BRAF 4,766 4 0.00 -1.00 0.00 0.50
Anemia 81,663 Disease Target CD34 24,598 509 0.01 -0.99 0.02 0.62
Anemia 81,663 Disease Target Elastase 13,875 12 0.00 -1.00 0.00 0.50
Overactive Bladder 3,492 Disease Target ALPP 80 1 0.00 -0.99 0.01 0.63
Overactive Bladder 3,492 Disease Target BDNF 11,163 7 0.00 -1.00 0.00 0.58
Overactive Bladder 3,492 Disease Target Equilibrative Nucleoside Transporter 1 211 1 0.00 -1.00 0.00 0.62
Cervical Cancer 28,286 Disease Target Cytokeratin 8 587 3 0.00 -1.00 0.01 0.57
Overactive Bladder 3,492 Disease Target BCHE 1,167 1 0.00 -1.00 0.00 0.58
Anemia 81,663 Disease Target BMPR1A 279 6 0.00 -0.99 0.02 0.57
Cervical Cancer 28,286 Disease Target Beta-Tubulin 4,870 7 0.00 -1.00 0.00 0.54
Cervical Cancer 28,286 Disease Target Calmodulin 25,240 4 0.00 -1.00 0.00 0.48
Anemia 81,663 Disease Target CXCL11 526 1 0.00 -1.00 0.00 0.52
Anemia 81,663 Disease Target DNA-damage-inducible transcript 3 30 2 0.00 -0.97 0.07 0.59
Cervical Cancer 28,286 Disease Target CA 72-4 184 3 0.00 -0.99 0.02 0.59
Cervical Cancer 28,286 Disease Target ENO2 87 2 0.00 -0.99 0.02 0.59
Cervical Cancer 28,286 Disease Target CCL18 256 1 0.00 -1.00 0.00 0.56
Cervical Cancer 28,286 Disease Target Angiotensin Converting Enzyme 31,674 1 0.00 -1.00 0.00 0.44
Cervical Cancer 28,286 Disease Target Aurora B kinase 415 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target Beta-Glucosidase 4,297 1 0.00 -1.00 0.00 0.50
Cervical Cancer 28,286 Disease Target CCNB1 160 1 0.00 -1.00 0.01 0.57